The efficacy and safety of intravenous propafenone was studied in 10 patients with Wolff-
Parkinson-White syndrome and in 2 patients with a concealed accessory pathway. During …

The electrophysiologic and long-term efficacy of propafenone, a relatively new
antiarrhythmic agent, was assessed in 47 patients with accessory pathways. In 23 patients …

The electrophysiologic effects of intravenous propafenone were studied in 15 consecutive
patients with accessory pathways. Thirteen patients had sustained orthodromic …

The antiarrhythmic effect of oral propafenone was evaluated in 10 patients with Wolff-
Parkinson-White syndrome presenting with non-ventricular arrhythmias (paroxysmal …

We compared the electrophysiological effects of intravenous propafenone andflecainide on
accessory pathway conduction by a randomized crossover study in 16 patients with Wolff …

The effects of intravenous procainamide (n= 30) or propafenone (n= 25) were evaluated in
55 patients with acute atrial fibrillation and the Wolff-Parkinson-White syndrome. All patients …

The electrophysiologic effects of intravenous (iv) and oral propafenone were evaluated in 14
patients with Wolff-Parkinson-White syndrome and in 10 patients with atrioventricular (AV) …

Like ajmaline, procainamide can be used to identify patients with the Wolff-Parkinson-White
syndrome who have a short refractory period of the accessory pathway in an anterograde …

To determine the reversibility of the effects of flecainide on accessory pathways,
etectrophysiologic studies were performed in the drug-free control state, after flecainide …

The effects of isoproterenol on accessory pathway conduction were evaluated in 24 patients
with intermittent and 60 patients with concealed pre-excitation, using ahial and ventricular …